MedTrace Logo

Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions

NCT05600803 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2023-11-27

No results posted yet for this study

Summary

This is the prospective observational study to explore whether the SpyGlass DS II system could be used to screen early-stage neoplastic bile duct lesions in selected patients.

Conditions

Interventions

PROCEDURE

Single-operator cholangioscopy

SpyGlass (Boston Scientific Co, Marlborough, USA) which enabled the direct visualization of the pancreaticobiliary system for the evaluation of intraductal lesions

Sponsors & Collaborators

  • Soonchunhyang University Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-30
Primary Completion
2025-10-30
Completion
2025-10-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05600803 on ClinicalTrials.gov